Document And Entity Information
Document And Entity Information - shares | 9 Months Ended | |
Sep. 30, 2021 | Nov. 12, 2021 | |
Document Information Line Items | ||
Entity Registrant Name | D and Z Media Acquisition Corp. | |
Document Type | 10-Q | |
Current Fiscal Year End Date | --12-31 | |
Amendment Flag | false | |
Entity Central Index Key | 0001830374 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Document Period End Date | Sep. 30, 2021 | |
Document Fiscal Year Focus | 2021 | |
Document Fiscal Period Focus | Q3 | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Shell Company | true | |
Entity Ex Transition Period | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity File Number | 001-39934 | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 85-3390360 | |
Entity Address, Address Line One | 2870 Peachtree Road NW | |
Entity Address, Address Line Two | Suite 509 | |
Entity Address, City or Town | Atlanta | |
Entity Address, State or Province | GA | |
Entity Address, Postal Zip Code | 30305 | |
City Area Code | (404) | |
Local Phone Number | 585-8233 | |
Entity Interactive Data Current | Yes | |
Units, each consisting of one share of Class A Common Stock and one-third of one Warrant | ||
Document Information Line Items | ||
Trading Symbol | DNZ.U | |
Title of 12(b) Security | Units, each consisting of one share of Class A Common Stock and one-third of one Warrant | |
Security Exchange Name | NYSE | |
Class A Common Stock, par value $0.0001 per share | ||
Document Information Line Items | ||
Trading Symbol | DNZ | |
Title of 12(b) Security | Class A Common Stock, par value $0.0001 per share | |
Security Exchange Name | NYSE | |
Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 | ||
Document Information Line Items | ||
Trading Symbol | DNZ WS | |
Title of 12(b) Security | Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 | |
Security Exchange Name | NYSE | |
Class A Common Stock | ||
Document Information Line Items | ||
Entity Common Stock, Shares Outstanding | 28,750,000 | |
Class B Common Stock | ||
Document Information Line Items | ||
Entity Common Stock, Shares Outstanding | 7,187,500 |
Condensed Balance Sheets
Condensed Balance Sheets - USD ($) | Sep. 30, 2021 | Dec. 31, 2020 |
CURRENT ASSETS: | ||
Cash | $ 894,816 | $ 9,325 |
Prepaid expenses | 370,621 | 1,971 |
Total current assets | 1,265,437 | 11,296 |
Prepaid expenses, net of current portion | 121,667 | |
Deferred offering costs | 219,620 | |
Marketable securities held in Trust Account | 287,510,322 | |
TOTAL ASSETS | 288,897,426 | 230,916 |
CURRENT LIABILITIES: | ||
Accounts payable and accrued expenses | 1,042,292 | 100,000 |
Promissory note - related party | 159,625 | |
Total current liabilities | 1,042,292 | 259,625 |
Working capital loan | 650,000 | |
Deferred underwriting fee payable | 10,062,500 | |
Warrant liability | 9,250,500 | |
TOTAL LIABILITIES | 21,005,292 | 259,625 |
Commitments (Note 7) | ||
Class A common stock subject to possible redemption, 28,750,000 and 0 at $10.00 redemption value as of September 30, 2021 and December 31, 2020, respectively | 287,500,000 | |
Stockholders’ equity (deficit): | ||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | ||
Class A common stock, $0.0001 par value; 200,000,000 shares authorized; no shares issued and outstanding | ||
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 7,187,500 shares issued and outstanding | 719 | 719 |
Additional paid-in capital | 180,000 | 24,281 |
Accumulated deficit | (19,788,585) | (53,709) |
Total stockholders’ (deficit) | (19,607,866) | (28,709) |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | $ 288,897,426 | $ 230,916 |
Condensed Balance Sheets (Paren
Condensed Balance Sheets (Parentheticals) - USD ($) | Sep. 30, 2021 | Dec. 31, 2020 |
Common stock, shares subject to possible redemption (in Dollars) | $ 28,750,000 | $ 0 |
Preferred stock par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, shares issued | ||
Preferred stock, shares outstanding | ||
Class A Common Stock | ||
Common stock par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 200,000,000 | 200,000,000 |
Common stock, shares issued | ||
Common stock, shares outstanding | ||
Class B Common Stock | ||
Common stock par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 20,000,000 | 20,000,000 |
Common stock, shares issued | 7,187,500 | 7,187,500 |
Common stock, shares outstanding | 7,187,500 | 7,187,500 |
Condensed Statements of Operati
Condensed Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | 9 Months Ended |
Sep. 30, 2021 | Sep. 30, 2021 | |
Formation and operating costs | $ (356,477) | $ (2,250,788) |
Loss from operations | (356,477) | (2,250,788) |
Other (loss) income | ||
Change in warrant liability | 4,653,833 | (389,500) |
Interest income | 2,977 | 10,322 |
Total other income (loss) | 4,656,810 | (379,178) |
Net income (loss) | $ 4,300,333 | $ (2,629,966) |
Redeemable Class A Common Stock | ||
Other (loss) income | ||
Weighted average shares outstanding (in Shares) | 28,750,000 | 25,801,282 |
Basic and diluted net income (loss) (in Dollars per share) | $ 0.12 | $ (0.08) |
Non-Redeemable Common Stock | ||
Other (loss) income | ||
Weighted average shares outstanding (in Shares) | 7,187,500 | 7,187,500 |
Basic and diluted net income (loss) (in Dollars per share) | $ 0.12 | $ (0.08) |
Condensed Statement of Changes
Condensed Statement of Changes in Stockholders' Equity (Unaudited) - USD ($) | Class ACommon Stock | Class BCommon Stock | Additional Paid-in Capital | Accumulated Deficit | Total |
Balance at Dec. 31, 2020 | $ 719 | $ 24,281 | $ (53,709) | $ (28,709) | |
Balance (in Shares) at Dec. 31, 2020 | 7,187,500 | ||||
Accretion for Class A common stock to redemption amount | (84,281) | (17,204,910) | (17,289,191) | ||
Executive compensation | 60,000 | 60,000 | |||
Net income (loss) | (1,263,760) | (1,263,760) | |||
Balance at Mar. 31, 2021 | $ 719 | (18,522,379) | (18,521,660) | ||
Balance (in Shares) at Mar. 31, 2021 | 7,187,500 | ||||
Executive compensation | 90,000 | 90,000 | |||
Net income (loss) | (5,566,539) | (5,566,539) | |||
Balance at Jun. 30, 2021 | $ 719 | 90,000 | (24,088,918) | (23,998,199) | |
Balance (in Shares) at Jun. 30, 2021 | 7,187,500 | ||||
Executive compensation | 90,000 | 90,000 | |||
Net income (loss) | 4,300,333 | 4,300,333 | |||
Balance at Sep. 30, 2021 | $ 719 | $ 180,000 | $ (19,788,585) | $ (19,607,866) | |
Balance (in Shares) at Sep. 30, 2021 | 7,187,500 |
Condensed Statement of Cash Flo
Condensed Statement of Cash Flows (Unaudited) | 9 Months Ended |
Sep. 30, 2021USD ($) | |
CASH FLOWS FROM OPERATING ACTIVITIES: | |
Net loss | $ (2,629,966) |
Adjustments to reconcile net loss to net cash used in operating activities: | |
Change in warrant liability | 389,500 |
Interest income earned on investment held in Trust Account | (10,322) |
Executive compensation | 240,000 |
Changes in operating assets and liabilities: | |
Prepaid expenses | (490,317) |
Accounts payable and accrued expenses | 942,292 |
Net cash used in operating activities | (1,558,813) |
CASH FLOWS FROM INVESTING ACTIVITIES: | |
Cash deposited into Trust Account | (287,500,000) |
Net cash used in investing activities | (287,500,000) |
CASH FLOWS FROM FINANCING ACTIVITIES: | |
Proceeds from sale of Units in Public Offering | 287,500,000 |
Proceeds from sale of Private Placement Warrants | 7,650,000 |
Proceeds of working capital loan | 650,000 |
Proceeds of promissory note - related party | 56,367 |
Payment of promissory note - related party | (215,992) |
Payment of offering costs | (5,696,071) |
Net cash provided by financing activities | 289,944,304 |
NET INCREASE IN CASH | 885,491 |
CASH BEGINNING OF PERIOD | 9,325 |
CASH END OF PERIOD | 894,816 |
SUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES: | |
Deferred underwriting commission charged to additional paid-in capital | 10,062,500 |
Initial classification of common stock subject to possible redemption | $ 287,500,000 |
Description of Organization and
Description of Organization and Business Operations | 9 Months Ended |
Sep. 30, 2021 | |
Accounting Policies [Abstract] | |
Description of Organization and Business Operations | Note 1—Description of Organization and Business Operations D and Z Media Acquisition Corp. (the “Company”) was incorporated in Delaware on October 7, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). Although the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company intends to focus its search for a target business in the media and education technology (ed-tech) sectors. The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. As of September 30, 2021, the Company had not commenced any operations. All activity through September 30, 2021 relates to the Company’s formation and the initial public offering (“IPO”) described below and since completion of the IPO, searching for a target with which to consummate a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO. The Company has selected December 31 st as its fiscal year end. The Company’s sponsor is D and Z Media Holdings LLC, a Delaware limited liability company (the “Sponsor”). Initial Public Offering On January 28, 2021, the Company consummated the IPO, including the full over-allotment option exercised by the underwriters on January 26, 2021, of 28,750,000 units (the “Units” and, with respect to the Class A common stock and warrants included in the Units, the “Public Shares” and “Public Warrants”, respectively), at $10.00 per Unit, generating gross proceeds of $287,500,000, which is discussed in Note 4. Simultaneously with the closing of the IPO, the Company consummated the sale of private placement warrants (“Private Placement Warrants”, and together with the Public Warrants, the “Warrants”) at a price of $1.50 per warrant in a private placement to the Sponsor and Loop Capital Markets LLC (“Loop”), generating gross proceeds of $7,650,000 which is described in Note 5. Initial Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 7) and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). Following the closing of the IPO on January 28, 2021, a total of $287,500,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a trust account (“Trust Account”), located in the United States and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account, as described below. The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to public stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 7). There will be no redemption rights upon the completion of a Business Combination with respect to the Warrants. The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law or stock exchange requirements and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Company’s initial stockholders, officers and directors have agreed to vote their Founder Shares (as defined in Note 6) and any Public Shares purchased during or after the IPO in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Company’s initial stockholders, officers and directors have agreed (i) to waive their redemption rights with respect to the Founder Shares and Public Shares held by them in connection with the completion of a Business Combination, (ii) not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation that would modify the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or with respect to any other material provisions relating to stockholders’ rights or pre-initial Business Combination activity, unless the Company provides the public stockholders with the opportunity to redeem their shares in conjunction with any such amendment and (iii) to waive their redemption rights with respect to the Founder Shares and Public Shares held by them in connection with a stockholder vote to approve an amendment referred to in clause (ii). The Company will have until January 28, 2023 to consummate a Business Combination (as such period may be extended pursuant to the Amended and Restated Certificate of Incorporation, the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes (less up to $100,000 to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period. The Company’s initial stockholders, officers and directors agreed to waive their right to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Company’s initial stockholders, officers or directors acquire Public Shares in or after the IPO, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commissions (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the IPO price per Unit ($10.00). In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. |
Significant Accounting Policies
Significant Accounting Policies | 9 Months Ended |
Sep. 30, 2021 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies | Note 2—Significant Accounting Policies Risks and Uncertainties On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus (the “COVID-19 outbreak”). In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the COVID-19 outbreak continues to evolve. The impact of the COVID-19 outbreak on the Company’s financial position will depend on future developments, including the duration and spread of the outbreak and related advisories and restrictions. These developments and the impact of the COVID-19 outbreak on the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy are impacted for an extended period, the Company’s financial position may be materially adversely affected. Additionally, the Company’s ability to complete an initial Business Combination may be materially adversely affected due to significant governmental measures being implemented to contain the COVID-19 outbreak or treat its impact, including travel restrictions, the shutdown of businesses and quarantines, among others, which may limit the Company’s ability to have meetings with potential investors or affect the ability of a potential target company’s personnel, vendors and service providers to negotiate and consummate an initial Business Combination in a timely manner. The Company’s ability to consummate an initial Business Combination may also be dependent on the ability to raise additional equity and debt financing, which may be impacted by the COVID-19 outbreak and the resulting market downturn. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC, and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for the fair presentation of the financial position as of September 30, 2021 and the results of operations and cash flows for the period presented and should be read in conjunction with the Company’s final prospectus for its IPO as filed with the SEC on January 27, 2021, as well as the Company’s Current Reports on Form 8-K, as filed with the SEC on January 29, February 3 (except as noted below), March 15 and September 30, 2021. The interim results for the period ended September 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future periods. As described in Note 3 – Restatement of Balance Sheet included in the Form 10-Q filed with the SEC on May 24, 2021, the Company’s balance sheet as of January 28, 2021 included in the Current Report on Form 8-K filed with the SEC on February 3, 2021 was misstated due to misapplication of accounting guidance related to the Warrants included in the audited balance sheet as of January 28, 2021. The restatement of the January 28, 2021 audited balance sheet was included in the Note 3 – Restatement of Balance Sheet in the Form 10-Q filed on May 24, 2021. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. Liquidity, Capital Resources and Going Concern As of September 30, 2021, the Company had $894,816 of cash and cash equivalents and working capital of $223,145. On September 28, 2021, the Company issued an unsecured promissory note to the Sponsor, whereby the Sponsor has agreed to loan up to $1,000,000 to the Company for working capital needs (the “Sponsor Working Capital Loan”). The Sponsor Working Capital Loan accrues no interest on the unpaid principal balance. The Sponsor Working Capital Loan is due on the earlier of (i) the date on which the Company consummates its initial Business Combination and (ii) the date that the winding up of the Company is effective. As of September 30, 2021, the Company has drawn down $650,000. Until consummation of its Business Combination, the Company will be using the funds not held in the Trust Account, and any additional Working Capital Loans (as defined in Note 6) for identifying and evaluating prospective acquisition candidates, performing business due diligence on prospective target businesses, traveling to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating the Business Combination. Due to the current liquidity position, including the addition of the Sponsor Working Capital Loan, management has since reevaluated the Company’s liquidity and financial condition and determined that sufficient capital exists to sustain operations for the next 12 months, and therefore the substantial doubt disclosed in the Form 10-Q filed on August 13, 2021 has been alleviated. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash and cash equivalents. The Company did not have any cash equivalents as of September 30, 2021 or December 31, 2020. Marketable Securities Held in Trust Account At September 30, 2021, the assets held in the Trust Account were held in money market funds which invest in U.S. Treasury securities. During the three months and nine months ended September 30, 2021, the Company did not withdraw any of the interest income from the Trust Account to pay its tax obligations. Fair Value Measurements Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 820 “Fair Value Measurements and Disclosures” (“ASC 820”) defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with the market approach, income approach and cost approach shall be used to measure fair value. ASC 820 establishes a fair value hierarchy for inputs, which represent the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances. The fair value hierarchy is categorized into three levels based on the inputs as follows: Level 1 – Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment. Level 2 – Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets and liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means. Level 3 – Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the condensed balance sheet as of September 30, 2021 and the balance sheet as of December 31, 2020. The fair values of cash and cash equivalents, prepaid assets, accounts payable and accrued expenses are estimated to approximate the carrying values as of September 30, 2021 and December 31, 2020 due to the short maturities of such instruments. Fair Value Measured as of September 30, 2021 Level 1 Level 2 Level 3 Total Assets: U.S. Treasury Securities held in Trust Account $ 287,510,322 $ - $ - $ 287,510,322 $ 287,510,322 $ - $ - $ 287,510,322 Liabilities: Private stock warrant liabilities $ - $ - $ 3,213,000 $ 3,213,000 Public stock warrant liabilities 6,037,500 - - 6,037,500 $ 6,037,500 $ - $ 3,213,000 $ 9,250,500 The Warrants are accounted for as liabilities pursuant to FASB ASC Topic 815-40, Derivatives and Hedging, Contracts in Entity’s Own Equity (“ASC 815-40”) and are measured at fair value as of each reporting period. Changes in the fair value of the Warrants are recorded in the statement of operations each period. As of September 30, 2021, the estimated fair value of the Public Warrants was determined by their public trading price and the estimated fair value of the Private Placement Warrants was determined using a Modified Black-Scholes valuation model using Level 3 inputs. Significant inputs to the valuation are as follows: As of Exercise price $ 11.50 Stock price 9.73 Volatility 15.00 % Term 5.00 Risk-free rate 0.98 % Dividend yield 0.00 % The following table presents a summary of the changes in the fair value of the Private Placement Warrants, a Level 3 liability, measured on a recurring basis. Warrant liabilities at December 31, 2020 $ - Issuance of private warrants 3,111,000 Change in fair value of warrant liabilities 102,000 Warrant liabilities at September 30, 2021 $ 3,213,000 Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. At September 30, 2021, the Company has not experienced losses on these accounts. Derivative warrant liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The 9,583,333 Public Warrants issued in connection with the IPO and the 5,100,000 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of the Warrants issued in connection with the IPO and private placement were initially measured at fair value using the Black-Scholes method for Private Placement Warrants and a Monte Carlo simulation model for Public Warrants. Subsequent to being publicly traded, the Company uses the publicly traded warrant price for Public Warrants and the Black-Scholes method for Private Placement Warrants to estimate fair value at each measurement date. Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) is classified as a liability instrument and measured at fair value. Conditionally redeemable Class A common stock (including common stock shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, shares of common stock are classified as stockholders’ equity. The Company’s common stock shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of September 30, 2021, 28,750,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. Offering Costs The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A-“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO and were charged to stockholders’ equity upon the completion of the IPO. Accordingly, as of September 30, 2021, offering costs in the aggregate of $15,978,191 have been charged to stockholders’ equity (consisting of $5,635,000 in cash underwriting fees, $9,861,250 in deferred underwriting fees and $481,941 of other offering costs). Use of Estimates The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities during the reporting period. Actual results could differ from those estimates. Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of September 30, 2021, the Company had deferred tax assets of approximately $602,000, which is presented net of a full valuation allowance. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. Net income (loss) Per Common Stock Shares The Company applies the two-class method in calculating net loss per common stock share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend of the purposes of the numerator in the earnings per share calculation. Net loss per common stock share is computed by dividing the pro rata net loss between the Class A common stock and the Class B common stock by the weighted average number of common stock outstanding for each of the periods. The calculation of diluted loss per common stock does not consider the effect of the Warrants sold in the IPO and private placement since the exercise of such Warrants is contingent upon the occurrence of future events and the inclusion of such Warrants would be anti-dilutive. The Warrants are exercisable for 14,683,333 shares of Class A common stock in the aggregate. Three Months Nine Months Class A Common Stock Numerator: Earnings allocable to Redeemable Class A Common Stock Net income (loss) allocable to Class A Common Stock subject to possible redemption $ 3,440,267 $ (2,056,957 ) Denominator: Weighted Average Class A Common Stock Basic and diluted weighted average shares outstanding 28,750,000 25,801,282 Basic and diluted net income per share $ 0.12 $ (0.08 ) Non-redeemable common stock Numerator: Net Loss minus Net Earnings Net loss allocable to non-redeemable common stock $ 860,067 $ (573,009 ) Denominator: Weighted Average non-redeemable common stock Basic and diluted weighted average shares outstanding 7,187,500 7,187,500 Basic and diluted net loss per share $ 0.12 $ (0.08 ) Recent Accounting Standards In August 2020, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. We are currently assessing the impact, if any, that ASU 2020-06 would have on our financial position, results of operations or cash flows. Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements. |
Restatement of Previously Issue
Restatement of Previously Issued Financial Statements | 9 Months Ended |
Sep. 30, 2021 | |
Revision Of Previously Issued Financial Statements [Abstract] | |
Restatement of Previously Issued Financial Statements | Note 3—Restatement of Previously Issued Financial Statements In the Company’s previously issued financial statements, a portion of the Public Shares were classified as permanent equity to maintain net tangible assets greater than $5,000,000 on the basis that the Company will consummate its initial Business Combination only if the Company has net tangible assets of at least $5,000,001. Thus, the company has historically classified a portion of Class A common stock in permanent equity to satisfy the $5,000,000 net tangible asset requirement. However, in light of recent comment letters issued by the SEC to several special purpose acquisition companies, management re-evaluated the Company’s application of ASC 480-10-S99-3A to its accounting classification of Public Shares. Upon re-evaluation, management determined that the Public Shares include certain provisions that require classification of the Public Shares as temporary equity regardless of the minimum net tangible asset required by the Company to complete its initial Business Combination. In accordance with SEC Staff Accounting Bulletin No. 99, “Materiality,” and SEC Staff Accounting Bulletin No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements,” the Company evaluated the changes and has determined that the related impact was material to the previously presented financial statements and those previously issued financial statements should no longer be relied upon. Therefore, the Company, in consultation with its Audit Committee, concluded that its previously issued financial statements should be restated to report all Public Shares as temporary equity. As such the Company is reporting these restatements to those periods in this Quarterly Report. Impact of the Restatement The impacts to the balance sheet as of January 28, 2021, March 31, 2021 and June 30, 2021 are presented below: As of January 28, 2021 As Previously Restatement As Restated Balance Sheet Warrant liabilities $ 8,861,000 $ - $ 8,861,000 Class A common stock, subject to possible redemption 264,932,430 22,567,570 (1) 287,500,000 Stockholders’ equity Preferred stock- $0.001 par value - - - Class A common stock, $0.0001 par value 226 (226 ) (1) - Class B common stock, $0.0001 par value 719 - 719 Additional paid-in-capital 5,402,434 (5,402,434 ) (1) - Retained earnings (deficit) (403,376 ) (17,164,910 ) (1) (17,568,286 ) Total stockholders’ equity $ 5,000,003 - $ (17,567,567 ) (1) To record the full value of Public Shares as temporary equity As of March 31, 2021 As Previously Restatement As Restated Balance Sheet Class A common stock, subject to possible redemption $ 263,978,330 $ 23,521,670 (1) $ 287,500,000 Stockholders’ equity Preferred stock- $0.001 par value - - - Class A common stock, $0.0001 par value 235 (235 (1) - Class B common stock, $0.0001 par value 719 - 719 Additional paid-in-capital 6,416,525 (6,416,525 (1) - Retained earnings (deficit) (1,417,469 ) (17,104,910 (1) (18,522,379 ) Total stockholders’ equity $ 5,000,010 $ - $ (18,521,660 ) (1) To record the full value of Public Shares as temporary equity As of June 30, 2021 As Previously Restatement As Restated Balance Sheet Class A common stock, subject to possible redemption 258,501,791 28,998,209 (1) 287,500,000 Stockholders’ equity Preferred stock- $0.001 par value - - - Class A common stock, $0.0001 par value 290 (290 (1) - Class B common stock, $0.0001 par value 719 - 719 Additional paid-in-capital 11,983,009 (11,893,009 (1) 90,000 Retained earnings (deficit) (6,984,008 ) (17,104,910 (1) (24,088,918 ) Total stockholders’ equity $ 5,000,010 - $ (23,998,199 ) (1) To record the full value of Public Shares as temporary equity |
Initial Public Offering
Initial Public Offering | 9 Months Ended |
Sep. 30, 2021 | |
Initial Public Offering [Abstract] | |
Initial Public Offering | Note 4—Initial Public Offering Pursuant to the IPO, the Company sold 28,750,000 Units at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one-third of one redeemable Public Warrant. Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price $11.50 per share, subject to adjustment. Each Public Warrant will become exercisable on the later of 30 days after the completion of the initial Business Combination or January 28, 2022 and will expire five years after the completion of the initial Business Combination or earlier upon redemption or liquidation (see Note 9). |
Private Placement
Private Placement | 9 Months Ended |
Sep. 30, 2021 | |
Private Placement [Abstract] | |
Private Placement | Note 5—Private Placement Simultaneously with the closing of the IPO, the Sponsor and Loop purchased 4,915,217 Private Placement Warrants and 184,783 Private Placement Warrants, respectively, for an aggregate of 5,100,000 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, for a total purchase price of $7,650,000 in a private placement. A portion of the proceeds from the private placement was added to the proceeds from the IPO held in the Trust Account. Each Private Placement Warrant is identical to the Public Warrants underlying the Units sold in the IPO, except that (1) the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (2) the Private Placement Warrants are non-redeemable, (3) the Private Placement Warrants may be exercised by the holders on a cashless basis and (4) the holders of the Private Placement Warrants (including with respect to the shares of Class A common stock issuable upon exercise of the Private Placement Warrants) are entitled to registration rights. If the Private Placement Warrants are held by someone other than the Sponsor, Loop or their permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption scenarios and exercisable by such holders on the same basis as the Public Warrants. In addition, the Private Placement Warrants held by Loop may not be exercised after January 25, 2026. |
Related Party Transactions
Related Party Transactions | 9 Months Ended |
Sep. 30, 2021 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Note 6—Related Party Transactions Founder Shares On October 19, 2020, the Sponsor subscribed to purchase 7,187,500 shares of the Company’s Class B common stock, par value $0.0001 per share (the “Founder Shares”), and fully paid for those shares on October 20, 2020. In December 2020, the Sponsor transferred 25,000 Founder Shares to each of Christine Zhao, Louise Sams, Scott Kurnit, Matt Blank and Dan Rosensweig and 50,000 Founder Shares to Brian Grazer at their original purchase price. In January 2021, the Sponsor transferred 100,000 Founder Shares to Loop at their original purchase price. The transfer of these Founder Shares resulted in the Sponsor holding 6,912,500 Founder Shares. The owners of the Founder Shares had agreed to forfeit up to 937,500 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriter, so that the Founder Shares represent 20% of the Company’s issued and outstanding shares after the IPO. The over-allotment was exercised in full on January 26, 2021 and none of the shares were forfeited. The initial stockholders have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Related Party Loans On October 19, 2020, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the IPO pursuant to a promissory note (the “Note”). This loan was non-interest bearing and payable on the earlier of March 31, 2021 and the completion or abandonment of the IPO. As of December 31, 2020, the Company had an outstanding balance of $159,625 and received an additional $56,367 of loan proceeds in January 2021. The total loan balance outstanding of $215,992 was paid back on January 29, 2021. In addition, in order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. On September 28, 2021, the Company issued an unsecured promissory note to the Sponsor, whereby the Sponsor has agreed to loan up to $1,000,000 to the Company for working capital needs. The Sponsor Working Capital Loan accrues no interest on the unpaid principal balance. The Sponsor Working Capital Loan is due on the earlier of (i) the date on which the Company consummates its initial Business Combination and (ii) the date that the winding up of the Company is effective. At the discretion of the Sponsor, the Sponsor Working Capital Loan may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. As of September 30, 2021, the Company had an outstanding balance of $650,000 under the Sponsor Working Capital Loan. Service and Administrative Fees The Company had agreed, commencing on January 26, 2021, to pay the Sponsor a total of $15,000 per month for office space, secretarial and administrative support until completion of the Business Combination or the Company’s liquidation. On May 25, 2021, the Company and the Sponsor agreed to cease such agreement. Service Agreement In February 2021, the Sponsor entered into a Strategic Services Agreement with the Company’s Chief Financial Officer (CFO) to provide services to the Company. The Sponsor agreed to pay the CFO $30,000 on a monthly basis for services until the earlier of the Company completing a Business Combination or January 31, 2022. In accordance with SEC Staff Accounting Bulletin (SAB) 5T, “Accounting for Expenses or Liabilities Paid by Principal Stockholder,” the Company recorded $90,000 and $240,000 as formation and operating costs with a credit to additional paid-in capital as executive compensation for the three month period ended September 30, 2021 and the nine month period ended September 30, 2021, respectively. |
Commitments & Contingencies
Commitments & Contingencies | 9 Months Ended |
Sep. 30, 2021 | |
Commitments Disclosure [Abstract] | |
Commitments & Contingencies | Note 7—Commitments & Contingencies Registration Rights The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares are entitled to registration rights pursuant to a registration rights agreement signed on January 25, 2021, the effective date of the IPO. These holders are entitled to certain demand and “piggyback” registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters are also entitled to $0.35 per Unit of the gross proceeds of the IPO, totaling $10,062,500. This fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. |
Stockholders_ Equity
Stockholders’ Equity | 9 Months Ended |
Sep. 30, 2021 | |
Stockholders' Equity Note [Abstract] | |
Stockholders’ Equity | Note 8—Stockholders’ Equity Preferred Stock Class A Common Stock Class B Common Stock Stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of the Class A common stock and holders of the Class B common stock will vote together as a single class on all matters submitted to a vote of the Company’s stockholders, except as required by law. The shares of Class B common stock will automatically convert into Class A common stock concurrently with or immediately following the consummation of the initial Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as described herein. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the IPO and related to the closing of the initial Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the then-outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by public stockholders), plus all shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued in connection with or in relation to the consummation of the initial Business Combination (excluding any shares of Class A common stock or equity-linked securities or rights issued or issuable to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor or an affiliate of the Sponsor or the Company’s officers and directors upon conversion of Working Capital Loans), minus the number of shares of Class A common stock redeemed in connection with the initial Business Combination, provided that such conversion will never occur on a less than one-for-one basis. |
Warrant Liabilities
Warrant Liabilities | 9 Months Ended |
Sep. 30, 2021 | |
Warrant Liablities [Abstract] | |
Warrant Liabilities | Note 9—Warrant Liabilities Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) January 28, 2022; provided in each case that the Company has an effective registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permits holders to exercise their Public Warrants on a cashless basis under the circumstances specified in the warrant agreement). The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use its best efforts to file, and within 60 business days following the initial Business Combination to have declared effective, a registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the Warrants and to maintain a current prospectus relating to those shares of Class A common stock until the Warrants expire or are redeemed; provided, that if the Class A common stock is at the time of any exercise of a Warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, but it will be required to use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The Warrants have an exercise price of $11.50 per share. If (x) the Company issue additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the initial stockholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s shares of Class A common stock during the 20 trading day period starting on the trading after the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of each warrant will be adjusted (to the nearest cent) such that the effective exercise price per full share will be equal to 115% of the higher of (i) the Market Value and (ii) the Newly Issued Price, and the $18.00 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 180% of the higher of (i) the Market Value and (ii) the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants, except that (1) the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (2) the Private Placement Warrants are non-redeemable, (3) the Private Placement Warrants may be exercised by the holders on a cashless basis and (4) the holders of the Private Placement Warrants (including with respect to the shares of Class A common stock issuable upon exercise of the Private Placement Warrants) are entitled to registration rights. If the Private Placement Warrants are held by someone other than the Sponsor, Loop or their permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption scenarios and exercisable by such holders on the same basis as the Public Warrants. In addition, the Private Placement Warrants held by Loop may not be exercised after January 25, 2026. The Company may call the Public Warrants for redemption: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption; and ● if, and only if, the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and for certain issuances of Class A common stock and equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination) for any 20 trading days within the 30-trading day period ending on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Warrants will not receive any of such funds with respect to their Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such Warrants. Accordingly, the Warrants may expire worthless. |
Subsequent Events
Subsequent Events | 9 Months Ended |
Sep. 30, 2021 | |
Subsequent Events [Abstract] | |
Subsequent Events | Note 10—Subsequent Events The Company evaluated events that have occurred after the balance sheet date through the date on which the financial statements were issued. Based upon this review, the Company did not identify any events that would have required adjustment or disclosure in the financial statements. |
Accounting Policies, by Policy
Accounting Policies, by Policy (Policies) | 9 Months Ended |
Sep. 30, 2021 | |
Accounting Policies [Abstract] | |
Risks and Uncertainties | Risks and Uncertainties On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus (the “COVID-19 outbreak”). In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the COVID-19 outbreak continues to evolve. The impact of the COVID-19 outbreak on the Company’s financial position will depend on future developments, including the duration and spread of the outbreak and related advisories and restrictions. These developments and the impact of the COVID-19 outbreak on the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy are impacted for an extended period, the Company’s financial position may be materially adversely affected. Additionally, the Company’s ability to complete an initial Business Combination may be materially adversely affected due to significant governmental measures being implemented to contain the COVID-19 outbreak or treat its impact, including travel restrictions, the shutdown of businesses and quarantines, among others, which may limit the Company’s ability to have meetings with potential investors or affect the ability of a potential target company’s personnel, vendors and service providers to negotiate and consummate an initial Business Combination in a timely manner. The Company’s ability to consummate an initial Business Combination may also be dependent on the ability to raise additional equity and debt financing, which may be impacted by the COVID-19 outbreak and the resulting market downturn. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. |
Basis of Presentation | Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC, and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for the fair presentation of the financial position as of September 30, 2021 and the results of operations and cash flows for the period presented and should be read in conjunction with the Company’s final prospectus for its IPO as filed with the SEC on January 27, 2021, as well as the Company’s Current Reports on Form 8-K, as filed with the SEC on January 29, February 3 (except as noted below), March 15 and September 30, 2021. The interim results for the period ended September 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future periods. As described in Note 3 – Restatement of Balance Sheet included in the Form 10-Q filed with the SEC on May 24, 2021, the Company’s balance sheet as of January 28, 2021 included in the Current Report on Form 8-K filed with the SEC on February 3, 2021 was misstated due to misapplication of accounting guidance related to the Warrants included in the audited balance sheet as of January 28, 2021. The restatement of the January 28, 2021 audited balance sheet was included in the Note 3 – Restatement of Balance Sheet in the Form 10-Q filed on May 24, 2021. |
Emerging Growth Company | Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. |
Liquidity, Capital Resources and Going Concern | Liquidity, Capital Resources and Going Concern As of September 30, 2021, the Company had $894,816 of cash and cash equivalents and working capital of $223,145. On September 28, 2021, the Company issued an unsecured promissory note to the Sponsor, whereby the Sponsor has agreed to loan up to $1,000,000 to the Company for working capital needs (the “Sponsor Working Capital Loan”). The Sponsor Working Capital Loan accrues no interest on the unpaid principal balance. The Sponsor Working Capital Loan is due on the earlier of (i) the date on which the Company consummates its initial Business Combination and (ii) the date that the winding up of the Company is effective. As of September 30, 2021, the Company has drawn down $650,000. Until consummation of its Business Combination, the Company will be using the funds not held in the Trust Account, and any additional Working Capital Loans (as defined in Note 6) for identifying and evaluating prospective acquisition candidates, performing business due diligence on prospective target businesses, traveling to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating the Business Combination. Due to the current liquidity position, including the addition of the Sponsor Working Capital Loan, management has since reevaluated the Company’s liquidity and financial condition and determined that sufficient capital exists to sustain operations for the next 12 months, and therefore the substantial doubt disclosed in the Form 10-Q filed on August 13, 2021 has been alleviated. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash and cash equivalents. The Company did not have any cash equivalents as of September 30, 2021 or December 31, 2020. |
Marketable Securities Held in Trust Account | Marketable Securities Held in Trust Account At September 30, 2021, the assets held in the Trust Account were held in money market funds which invest in U.S. Treasury securities. During the three months and nine months ended September 30, 2021, the Company did not withdraw any of the interest income from the Trust Account to pay its tax obligations. |
Fair Value Measurements | Fair Value Measurements Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 820 “Fair Value Measurements and Disclosures” (“ASC 820”) defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with the market approach, income approach and cost approach shall be used to measure fair value. ASC 820 establishes a fair value hierarchy for inputs, which represent the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances. The fair value hierarchy is categorized into three levels based on the inputs as follows: Level 1 – Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment. Level 2 – Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets and liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means. Level 3 – Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the condensed balance sheet as of September 30, 2021 and the balance sheet as of December 31, 2020. The fair values of cash and cash equivalents, prepaid assets, accounts payable and accrued expenses are estimated to approximate the carrying values as of September 30, 2021 and December 31, 2020 due to the short maturities of such instruments. Fair Value Measured as of September 30, 2021 Level 1 Level 2 Level 3 Total Assets: U.S. Treasury Securities held in Trust Account $ 287,510,322 $ - $ - $ 287,510,322 $ 287,510,322 $ - $ - $ 287,510,322 Liabilities: Private stock warrant liabilities $ - $ - $ 3,213,000 $ 3,213,000 Public stock warrant liabilities 6,037,500 - - 6,037,500 $ 6,037,500 $ - $ 3,213,000 $ 9,250,500 The Warrants are accounted for as liabilities pursuant to FASB ASC Topic 815-40, Derivatives and Hedging, Contracts in Entity’s Own Equity (“ASC 815-40”) and are measured at fair value as of each reporting period. Changes in the fair value of the Warrants are recorded in the statement of operations each period. As of September 30, 2021, the estimated fair value of the Public Warrants was determined by their public trading price and the estimated fair value of the Private Placement Warrants was determined using a Modified Black-Scholes valuation model using Level 3 inputs. Significant inputs to the valuation are as follows: As of Exercise price $ 11.50 Stock price 9.73 Volatility 15.00 % Term 5.00 Risk-free rate 0.98 % Dividend yield 0.00 % The following table presents a summary of the changes in the fair value of the Private Placement Warrants, a Level 3 liability, measured on a recurring basis. Warrant liabilities at December 31, 2020 $ - Issuance of private warrants 3,111,000 Change in fair value of warrant liabilities 102,000 Warrant liabilities at September 30, 2021 $ 3,213,000 |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. At September 30, 2021, the Company has not experienced losses on these accounts. |
Derivative warrant liabilities | Derivative warrant liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The 9,583,333 Public Warrants issued in connection with the IPO and the 5,100,000 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of the Warrants issued in connection with the IPO and private placement were initially measured at fair value using the Black-Scholes method for Private Placement Warrants and a Monte Carlo simulation model for Public Warrants. Subsequent to being publicly traded, the Company uses the publicly traded warrant price for Public Warrants and the Black-Scholes method for Private Placement Warrants to estimate fair value at each measurement date. |
Common Stock Subject to Possible Redemption | Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) is classified as a liability instrument and measured at fair value. Conditionally redeemable Class A common stock (including common stock shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, shares of common stock are classified as stockholders’ equity. The Company’s common stock shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of September 30, 2021, 28,750,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. |
Offering Costs | Offering Costs The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A-“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO and were charged to stockholders’ equity upon the completion of the IPO. Accordingly, as of September 30, 2021, offering costs in the aggregate of $15,978,191 have been charged to stockholders’ equity (consisting of $5,635,000 in cash underwriting fees, $9,861,250 in deferred underwriting fees and $481,941 of other offering costs). |
Use of Estimates | Use of Estimates The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities during the reporting period. Actual results could differ from those estimates. |
Income Taxes | Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of September 30, 2021, the Company had deferred tax assets of approximately $602,000, which is presented net of a full valuation allowance. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. |
Net income (loss) Per Common Stock Shares | Net income (loss) Per Common Stock Shares The Company applies the two-class method in calculating net loss per common stock share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of stock. Changes in fair value are not considered a dividend of the purposes of the numerator in the earnings per share calculation. Net loss per common stock share is computed by dividing the pro rata net loss between the Class A common stock and the Class B common stock by the weighted average number of common stock outstanding for each of the periods. The calculation of diluted loss per common stock does not consider the effect of the Warrants sold in the IPO and private placement since the exercise of such Warrants is contingent upon the occurrence of future events and the inclusion of such Warrants would be anti-dilutive. The Warrants are exercisable for 14,683,333 shares of Class A common stock in the aggregate. Three Months Nine Months Class A Common Stock Numerator: Earnings allocable to Redeemable Class A Common Stock Net income (loss) allocable to Class A Common Stock subject to possible redemption $ 3,440,267 $ (2,056,957 ) Denominator: Weighted Average Class A Common Stock Basic and diluted weighted average shares outstanding 28,750,000 25,801,282 Basic and diluted net income per share $ 0.12 $ (0.08 ) Non-redeemable common stock Numerator: Net Loss minus Net Earnings Net loss allocable to non-redeemable common stock $ 860,067 $ (573,009 ) Denominator: Weighted Average non-redeemable common stock Basic and diluted weighted average shares outstanding 7,187,500 7,187,500 Basic and diluted net loss per share $ 0.12 $ (0.08 ) |
Recent Accounting Standards | Recent Accounting Standards In August 2020, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. We are currently assessing the impact, if any, that ASU 2020-06 would have on our financial position, results of operations or cash flows. Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements. |
Significant Accounting Polici_2
Significant Accounting Policies (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Accounting Policies [Abstract] | |
Schedule of the fair values of cash and cash equivalents, prepaid assets, accounts payable and accrued expenses | Fair Value Measured as of September 30, 2021 Level 1 Level 2 Level 3 Total Assets: U.S. Treasury Securities held in Trust Account $ 287,510,322 $ - $ - $ 287,510,322 $ 287,510,322 $ - $ - $ 287,510,322 Liabilities: Private stock warrant liabilities $ - $ - $ 3,213,000 $ 3,213,000 Public stock warrant liabilities 6,037,500 - - 6,037,500 $ 6,037,500 $ - $ 3,213,000 $ 9,250,500 |
Schedule of significant inputs to the valuation | As of Exercise price $ 11.50 Stock price 9.73 Volatility 15.00 % Term 5.00 Risk-free rate 0.98 % Dividend yield 0.00 % |
Schedule of measured on a recurring basis | Warrant liabilities at December 31, 2020 $ - Issuance of private warrants 3,111,000 Change in fair value of warrant liabilities 102,000 Warrant liabilities at September 30, 2021 $ 3,213,000 |
Schedule of non-redeemable common stock shares’ proportionate interest | Three Months Nine Months Class A Common Stock Numerator: Earnings allocable to Redeemable Class A Common Stock Net income (loss) allocable to Class A Common Stock subject to possible redemption $ 3,440,267 $ (2,056,957 ) Denominator: Weighted Average Class A Common Stock Basic and diluted weighted average shares outstanding 28,750,000 25,801,282 Basic and diluted net income per share $ 0.12 $ (0.08 ) Non-redeemable common stock Numerator: Net Loss minus Net Earnings Net loss allocable to non-redeemable common stock $ 860,067 $ (573,009 ) Denominator: Weighted Average non-redeemable common stock Basic and diluted weighted average shares outstanding 7,187,500 7,187,500 Basic and diluted net loss per share $ 0.12 $ (0.08 ) |
Restatement of Previously Iss_2
Restatement of Previously Issued Financial Statements (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Revision Of Previously Issued Financial Statements [Abstract] | |
Schedule of balance sheet | As of January 28, 2021 As Previously Restatement As Restated Balance Sheet Warrant liabilities $ 8,861,000 $ - $ 8,861,000 Class A common stock, subject to possible redemption 264,932,430 22,567,570 (1) 287,500,000 Stockholders’ equity Preferred stock- $0.001 par value - - - Class A common stock, $0.0001 par value 226 (226 ) (1) - Class B common stock, $0.0001 par value 719 - 719 Additional paid-in-capital 5,402,434 (5,402,434 ) (1) - Retained earnings (deficit) (403,376 ) (17,164,910 ) (1) (17,568,286 ) Total stockholders’ equity $ 5,000,003 - $ (17,567,567 ) (1) To record the full value of Public Shares as temporary equity As of March 31, 2021 As Previously Restatement As Restated Balance Sheet Class A common stock, subject to possible redemption $ 263,978,330 $ 23,521,670 (1) $ 287,500,000 Stockholders’ equity Preferred stock- $0.001 par value - - - Class A common stock, $0.0001 par value 235 (235 (1) - Class B common stock, $0.0001 par value 719 - 719 Additional paid-in-capital 6,416,525 (6,416,525 (1) - Retained earnings (deficit) (1,417,469 ) (17,104,910 (1) (18,522,379 ) Total stockholders’ equity $ 5,000,010 $ - $ (18,521,660 ) As of June 30, 2021 As Previously Restatement As Restated Balance Sheet Class A common stock, subject to possible redemption 258,501,791 28,998,209 (1) 287,500,000 Stockholders’ equity Preferred stock- $0.001 par value - - - Class A common stock, $0.0001 par value 290 (290 (1) - Class B common stock, $0.0001 par value 719 - 719 Additional paid-in-capital 11,983,009 (11,893,009 (1) 90,000 Retained earnings (deficit) (6,984,008 ) (17,104,910 (1) (24,088,918 ) Total stockholders’ equity $ 5,000,010 - $ (23,998,199 ) |
Description of Organization a_2
Description of Organization and Business Operations (Details) - USD ($) | 1 Months Ended | 9 Months Ended |
Jan. 28, 2021 | Sep. 30, 2021 | |
Description of Organization and Business Operations (Details) [Line Items] | ||
Shares price per unit | $ 18 | |
Gross proceeds (in Dollars) | $ 287,500,000 | $ 287,500,000 |
Fair market value percentage | 80.00% | |
Sale of per share price | $ 10 | |
Net tangible assets (in Dollars) | $ 5,000,001 | |
Aggregate public shares, percentage | 15.00% | |
Redemption of public shares percentage | 100.00% | |
Dissolution expenses (in Dollars) | $ 100,000 | |
Public per share price | $ 10 | |
IPO [Member] | ||
Description of Organization and Business Operations (Details) [Line Items] | ||
Shares issued (in Shares) | 28,750,000 | 28,750,000 |
Shares price per unit | $ 10 | $ 10 |
Gross proceeds (in Dollars) | $ 287,500,000 | |
IPO [Member] | ||
Description of Organization and Business Operations (Details) [Line Items] | ||
Shares price per unit | $ 1.5 | |
Gross proceeds of private placement (in Dollars) | $ 7,650,000 | |
Initial Stockholders [Member] | ||
Description of Organization and Business Operations (Details) [Line Items] | ||
Shares price per unit | $ 10 | |
Public per share price | $ 10 | |
Investment Company [Member] | ||
Description of Organization and Business Operations (Details) [Line Items] | ||
Percentage of issued and outstanding voting securities | 50.00% |
Significant Accounting Polici_3
Significant Accounting Policies (Details) - USD ($) | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 28, 2021 | Dec. 31, 2020 | |
Significant Accounting Policies (Details) [Line Items] | |||
Cash and cash equivalents | $ 894,816 | $ 9,325 | |
Working capital | 223,145 | ||
Company drawn down | 650,000 | ||
Federal depository insurance coverage | $ 250,000 | ||
Possible redemtion common stock (in Shares) | 28,750,000 | ||
Aggregate Offering Cost | $ 15,978,191 | ||
Underwriters fee | 5,635,000 | ||
Deferred underwriting fees | 9,861,250 | ||
Other offering cost | 481,941 | ||
Deferred tax assets | $ 602,000 | ||
Private placement purchase an aggregate (in Shares) | 14,683,333 | ||
IPO [Member] | |||
Significant Accounting Policies (Details) [Line Items] | |||
Public warrants (in Shares) | 9,583,333 | ||
Private placement warrants (in Shares) | 5,100,000 | ||
Promissory Note [Member] | |||
Significant Accounting Policies (Details) [Line Items] | |||
Aggregate loan amount | $ 1,000,000 |
Significant Accounting Polici_4
Significant Accounting Policies (Details) - Schedule of the fair values of cash and cash equivalents, prepaid assets, accounts payable and accrued expenses | Sep. 30, 2021USD ($) |
Assets: | |
U.S. Treasury Securities held in Trust Account | $ 287,510,322 |
Total | 287,510,322 |
Liabilities: | |
Private stock warrant liabilities | 3,213,000 |
Public stock warrant liabilities | 6,037,500 |
Total | 9,250,500 |
Level 1 [Member] | |
Assets: | |
U.S. Treasury Securities held in Trust Account | 287,510,322 |
Total | 287,510,322 |
Liabilities: | |
Private stock warrant liabilities | |
Public stock warrant liabilities | 6,037,500 |
Total | 6,037,500 |
Level 2 [Member] | |
Assets: | |
U.S. Treasury Securities held in Trust Account | |
Total | |
Liabilities: | |
Private stock warrant liabilities | |
Public stock warrant liabilities | |
Total | |
Level 3 [Member] | |
Assets: | |
U.S. Treasury Securities held in Trust Account | |
Total | |
Liabilities: | |
Private stock warrant liabilities | 3,213,000 |
Public stock warrant liabilities | |
Total | $ 3,213,000 |
Significant Accounting Polici_5
Significant Accounting Policies (Details) - Schedule of significant inputs to the valuation | 9 Months Ended |
Sep. 30, 2021$ / shares | |
Schedule of significant inputs to the valuation [Abstract] | |
Exercise price (in Dollars per share) | $ 11.5 |
Stock price (in Dollars per share) | $ 9.73 |
Volatility | 15.00% |
Term | 5 years |
Risk-free rate | 0.98% |
Dividend yield | 0.00% |
Significant Accounting Polici_6
Significant Accounting Policies (Details) - Schedule of measured on a recurring basis | 9 Months Ended |
Sep. 30, 2021USD ($) | |
Schedule of measured on a recurring basis [Abstract] | |
Warrant liabilities at December 31, 2020 | |
Issuance of private warrants | 3,111,000 |
Change in fair value of warrant liabilities | 102,000 |
Warrant liabilities at September 30, 2021 | $ 3,213,000 |
Significant Accounting Polici_7
Significant Accounting Policies (Details) - Schedule of non-redeemable common stock shares’ proportionate interest - USD ($) | 3 Months Ended | 9 Months Ended |
Sep. 30, 2021 | Sep. 30, 2021 | |
Redeemable Class A Common Stock [Member] | ||
Numerator: Earnings allocable to Redeemable Class A Common Stock | ||
Net income (loss) allocable to Class A Common Stock subject to possible redemption | $ 3,440,267 | $ (2,056,957) |
Basic and diluted weighted average shares outstanding | 28,750,000 | 25,801,282 |
Basic and diluted net income per share | $ 0.12 | $ (0.08) |
Non-Redeemable Class A and Class B Common Stock [Member] | ||
Numerator: Net Loss minus Net Earnings | ||
Net loss allocable to non-redeemable common stock | $ 860,067 | $ (573,009) |
Basic and diluted weighted average shares outstanding | 7,187,500 | 7,187,500 |
Basic and diluted net loss per share | $ 0.12 | $ (0.08) |
Restatement of Previously Iss_3
Restatement of Previously Issued Financial Statements (Details) | Sep. 30, 2021USD ($) |
Restatement of Previously Issued Financial Statements (Details) [Line Items] | |
Net tangible assets | $ 5,000,000 |
Business Combination [Member] | |
Restatement of Previously Issued Financial Statements (Details) [Line Items] | |
Net tangible assets | 5,000,001 |
Class A Common Stock [Member] | |
Restatement of Previously Issued Financial Statements (Details) [Line Items] | |
Net tangible assets | $ 5,000,000 |
Restatement of Previously Iss_4
Restatement of Previously Issued Financial Statements (Details) - Schedule of balance sheet - USD ($) | Jun. 30, 2021 | Mar. 31, 2021 | Jan. 28, 2021 | |
As Previously Reported [Member] | ||||
Balance Sheet | ||||
Warrant liabilities | $ 8,861,000 | |||
Class A common stock, subject to possible redemption Total | [1] | 264,932,430 | ||
Class A common stock, subject to possible redemption | $ 258,501,791 | $ 263,978,330 | ||
Stockholders’ equity | ||||
Preferred stock- $0.001 par value | ||||
Class A common stock, $0.0001 par value | 290 | 235 | ||
Class A common stock, $0.0001 par value Total | [1] | 226 | ||
Class B common stock, $0.0001 par value | 719 | 719 | 719 | |
Additional paid-in-capital | 11,983,009 | 6,416,525 | ||
Retained earnings (deficit) | (6,984,008) | (1,417,469) | ||
Additional paid-in-capital Total | [1] | 5,402,434 | ||
Retained earnings (deficit) Total | [1] | (403,376) | ||
Total stockholders’ equity | 5,000,010 | 5,000,010 | 5,000,003 | |
As Previously Reported [Member] | ||||
Balance Sheet | ||||
Warrant liabilities | ||||
Class A common stock, subject to possible redemption Total | 22,567,570 | |||
Class A common stock, subject to possible redemption | 28,998,209 | 23,521,670 | ||
Stockholders’ equity | ||||
Preferred stock- $0.001 par value | ||||
Class A common stock, $0.0001 par value | ||||
Class A common stock, $0.0001 par value Total | (226) | |||
Class B common stock, $0.0001 par value | ||||
Additional paid-in-capital | ||||
Retained earnings (deficit) | ||||
Additional paid-in-capital Total | (5,402,434) | |||
Retained earnings (deficit) Total | (17,164,910) | |||
Total stockholders’ equity | ||||
As Revised [Member] | ||||
Balance Sheet | ||||
Warrant liabilities | 8,861,000 | |||
Class A common stock, subject to possible redemption Total | 287,500,000 | |||
Class A common stock, subject to possible redemption | 287,500,000 | 287,500,000 | ||
Stockholders’ equity | ||||
Preferred stock- $0.001 par value | ||||
Class A common stock, $0.0001 par value | ||||
Class B common stock, $0.0001 par value | 719 | 719 | 719 | |
Additional paid-in-capital | 90,000 | |||
Retained earnings (deficit) | (24,088,918) | (18,522,379) | ||
Retained earnings (deficit) Total | (17,568,286) | |||
Total stockholders’ equity | $ (23,998,199) | $ (18,521,660) | $ (17,567,567) | |
[1] | To record the full value of Public Shares as temporary equity |
Initial Public Offering (Detail
Initial Public Offering (Details) - $ / shares | 1 Months Ended | 9 Months Ended |
Jan. 28, 2021 | Sep. 30, 2021 | |
Initial Public Offering (Details) [Line Items] | ||
Sale of price per share | $ 18 | |
Business combination expire term | 5 years | |
IPO [Member] | ||
Initial Public Offering (Details) [Line Items] | ||
Number of units issued in transaction (in Shares) | 28,750,000 | 28,750,000 |
Sale of price per share | $ 10 | $ 10 |
Class A Common Stock [Member] | ||
Initial Public Offering (Details) [Line Items] | ||
Sale of price per share | $ 11.5 |
Private Placement (Details)
Private Placement (Details) | 9 Months Ended |
Sep. 30, 2021USD ($)$ / sharesshares | |
Private Placement (Details) [Line Items] | |
Total purchase price (in Dollars) | $ | $ 7,650,000 |
IPO [Member] | |
Private Placement (Details) [Line Items] | |
Sponsor purchased shares | 4,915,217 |
Private Placement [Member] | |
Private Placement (Details) [Line Items] | |
Sponsor purchased shares | 184,783 |
Aggregate shares | 5,100,000 |
Warrant price per share (in Dollars per share) | $ / shares | $ 1.5 |
Related Party Transactions (Det
Related Party Transactions (Details) - USD ($) | Oct. 19, 2020 | Jan. 26, 2021 | Jun. 30, 2021 | Sep. 30, 2021 | Jan. 29, 2021 | Dec. 31, 2020 |
Related Party Transactions (Details) [Line Items] | ||||||
Founder shares, description | In December 2020, the Sponsor transferred 25,000 Founder Shares to each of Christine Zhao, Louise Sams, Scott Kurnit, Matt Blank and Dan Rosensweig and 50,000 Founder Shares to Brian Grazer at their original purchase price. In January 2021, the Sponsor transferred 100,000 Founder Shares to Loop at their original purchase price. The transfer of these Founder Shares resulted in the Sponsor holding 6,912,500 Founder Shares. The owners of the Founder Shares had agreed to forfeit up to 937,500 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriter, so that the Founder Shares represent 20% of the Company’s issued and outstanding shares after the IPO. The over-allotment was exercised in full on January 26, 2021 and none of the shares were forfeited. | |||||
Initial stockholders description | The initial stockholders have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. | |||||
Promissory note | $ 300,000 | |||||
Outstanding balance | $ 159,625 | |||||
Loan amount | $ 56,367 | |||||
Total loan amount repayment | $ 215,992 | |||||
Working capital | $ 1,500,000 | |||||
Liquidation aggregate | $ 15,978,191 | |||||
Administrative office fees expenses | $ 15,000 | |||||
Service agreement description | The Sponsor agreed to pay the CFO $30,000 on a monthly basis for services until the earlier of the Company completing a Business Combination or January 31, 2022. In accordance with SEC Staff Accounting Bulletin (SAB) 5T, “Accounting for Expenses or Liabilities Paid by Principal Stockholder,” the Company recorded $90,000 and $240,000 as formation and operating costs with a credit to additional paid-in capital as executive compensation for the three month period ended September 30, 2021 and the nine month period ended September 30, 2021, respectively. | |||||
Related Party Loans [Member] | ||||||
Related Party Transactions (Details) [Line Items] | ||||||
Liquidation aggregate | $ 1,000,000 | |||||
Sponsor [Member] | ||||||
Related Party Transactions (Details) [Line Items] | ||||||
Working capital | $ 650,000 | |||||
Warrant price per share (in Dollars per share) | $ 1.5 | |||||
Additional Paid-in Capital [Member] | ||||||
Related Party Transactions (Details) [Line Items] | ||||||
General and administrative expense | $ 90,000 | |||||
Private Placement [Member] | ||||||
Related Party Transactions (Details) [Line Items] | ||||||
Aggregate of common shares (in Shares) | 5,100,000 | |||||
Warrant price per share (in Dollars per share) | $ 1.5 | |||||
Class B Common Stock [Member] | ||||||
Related Party Transactions (Details) [Line Items] | ||||||
Common stock par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | ||||
Class B Common Stock [Member] | Sponsor [Member] | ||||||
Related Party Transactions (Details) [Line Items] | ||||||
Aggregate of common shares (in Shares) | 7,187,500 | |||||
Common stock par value (in Dollars per share) | $ 0.0001 |
Commitments & Contingencies (De
Commitments & Contingencies (Details) | 9 Months Ended |
Sep. 30, 2021USD ($)$ / shares | |
Commitments & Contingencies (Details) [Line Items] | |
Public offering per share | $ / shares | $ 0.35 |
IPO [Member] | |
Commitments & Contingencies (Details) [Line Items] | |
Aggregate of proposed public offering | $ | $ 10,062,500 |
Stockholders_ Equity (Details)
Stockholders’ Equity (Details) - $ / shares | 1 Months Ended | 9 Months Ended | 12 Months Ended |
Jan. 31, 2021 | Sep. 30, 2021 | Dec. 31, 2020 | |
Stockholders’ Equity (Details) [Line Items] | |||
Preferred stock, shares authorized | 1,000,000 | 1,000,000 | |
Preferred stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | |
Original purchase price | 100,000 | 50,000 | |
Founder holding shares | 6,912,500 | ||
Converted basis of common stock shares, percentage | 20.00% | ||
Christine Zhao [Member] | |||
Stockholders’ Equity (Details) [Line Items] | |||
Founder share | 25,000 | ||
Class A Common Stock [Member] | |||
Stockholders’ Equity (Details) [Line Items] | |||
Common stock, shares authorized | 200,000,000 | 200,000,000 | |
Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | |
Common stock, shares issued | 28,750,000 | ||
Class B Common Stock [Member] | |||
Stockholders’ Equity (Details) [Line Items] | |||
Common stock, shares authorized | 20,000,000 | 20,000,000 | |
Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | |
Common stock, shares issued | 7,187,500 |
Warrant Liabilities (Details)
Warrant Liabilities (Details) | 9 Months Ended |
Sep. 30, 2021$ / shares | |
Warrant Liabilities (Details) [Line Items] | |
Warrants and rights term | 5 years |
Price per share | $ 9.2 |
Gross proceeds | 60.00% |
Market value and newly issued price, per share percentage | 180.00% |
Redemption trigger price per share | $ 18 |
Common stock price per share | 18 |
Warrant [Member] | |
Warrant Liabilities (Details) [Line Items] | |
Warrants price per share | 0.01 |
Market value per share | $ 9.2 |
Market value and newly issued price, per share percentage | 115.00% |
Class A Common Stock [Member] | |
Warrant Liabilities (Details) [Line Items] | |
Warrants price per share | $ 11.5 |
Common stock price per share | $ 11.5 |